Strides Arcolab’s wholly owned subsidiary - Strides Pharma Global, Singapore (Strides Pharma Global) has been awarded ‘International Headquarters Status’ by the Singapore Economic Development Board (EDB). Strides Pharma Global proposes to carry out activities for its international business including business development and planning, sales and marketing, intellectual property management, global supply chain management and global regulatory affairs.
Strides Pharma Global will also be building a new manufacturing facility in Singapore in the next couple of years with focus on the regulated and South East Asia markets.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
